The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHZD.L Regulatory News (HZD)

  • There is currently no data for HZD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

12 Nov 2015 07:00

RNS Number : 4230F
Horizon Discovery Group plc
12 November 2015
 

 

For filings with the FCA include the annex

For filings with issuer exclude the annex

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

Horizon Discovery Group plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to thenotification obligation: iii

Aviva plc & its subsidiaries

4. Full name of shareholder(s)  (if different from 3.):iv

Registered Holder:

 

Available Upon Request 13,467*

 

BNY Norwich Union Nominees Limited 286,609*

 

Chase (GA Group) Nominees Limited 4,790,826*

* denotes direct interest

 

Chase (GA Group) Nominees Limited 1,056,577

Chase Nominees Limited 189,813

 

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

10 November 2015

6. Date on which issuer notified:

11 November 2015

7. Threshold(s) that is/are crossed orreached: vi, vii

4% to 5% Change at Direct Interest Level

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

Ordinary SharesGB00BK8FL363

5,872,292

5,872,292

6,337,292

5,090,902

1,246,390

5.41%

1.33%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

 

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

6,337,292

6.74%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

The voting rights are managed and controlled by Aviva Investors Global Services Limited & Friends Provident International Limited, with the following chains of controlled undertakings:-

 

Aviva Investors Global Services Limited:

· Aviva plc (Parent Company)

· Aviva Group Holdings Limited (wholly owned subsidiary of Aviva plc)

· Aviva Investors Holdings Limited (wholly owned subsidiary of Aviva Group Holdings Limited)

· Aviva Investors Global Services Limited (wholly owned subsidiary of Aviva Investors Holdings Limited)

 

Friends Provident International Limited:

· Aviva plc (Parent Company)

· Aviva Group Holdings Limited (wholly owned subsidiary of Aviva plc)

· Aviva Life Holdings UK Limited (wholly owned subsidiary of Aviva Group Holdings Limited)

· Friends Life FPG Limited (wholly owned subsidiary of Aviva Life Holdings UK Limited)

· Friends Life FPL Limited (wholly owned subsidiary of Friends Life FPG Limited)

· Friends Life Limited (wholly owned subsidiary of Friends Life FPL Limited)

· Friends Life and Pensions Limited (wholly owned subsidiary of Friends Life Limited)

· Friends Provident International Limited (wholly owned subsidiary of Friends Life and Pensions Limited)

 

Proxy Voting:

10. Name of the proxy holder:

See Section 4

11. Number of voting rights proxy holder will ceaseto hold:

12. Date on which proxy holder will cease to holdvoting rights:

 

 

13. Additional information:

Figures are based on a total number of voting rights of 94,087,603 as per the Company's Total Voting Rights Announcement of 29 October 2015.

 

14. Contact name:

Neil Whittaker, Aviva plc

15. Contact telephone number:

01603 684420

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLBBBRTMBBBBLA
Date   Source Headline
8th Jul 20207:00 amRNSNotice of Trading Update & Capital Markets Webinar
26th Jun 20207:00 amRNSDirector/PDMR Shareholding
18th Jun 20201:00 pmRNSResult of AGM
18th Jun 20201:00 pmRNSDirector/PDMR Shareholding
5th Jun 20205:34 pmRNSHolding(s) in Company
4th Jun 202011:11 amRNSHoldings in Company
29th May 20207:00 amRNSDirector/PDMR Shareholding
22nd May 20207:00 amRNSAnnual Report and Notice of AGM
5th May 20205:46 pmRNSHolding(s) in Company
5th May 20201:34 pmRNSHolding(s) in Company
4th May 20201:58 pmRNSDirector/PDMR Shareholding
4th May 20207:00 amRNSDirector/PDMR Shareholding
1st May 20207:00 amRNSBoard Changes
29th Apr 202010:43 amRNSHolding(s) in Company
27th Apr 20207:00 amRNSFull Year Unaudited Results 2019
17th Apr 20203:56 pmRNSResults of Placing
17th Apr 202011:00 amRNSProposed Placing and COVID-19 update
3rd Apr 202011:35 amRNSHolding(s) in Company
2nd Apr 20204:40 pmRNSSecond Price Monitoring Extn
2nd Apr 20204:36 pmRNSPrice Monitoring Extension
1st Apr 202010:56 amRNSHoldings in Company
27th Mar 20207:00 amRNSFull Year Results Deferral and COVID-19 Update
25th Mar 202011:20 amRNSHolding(s) in Company
19th Mar 20204:43 pmRNSSecond Price Monitoring Extn
19th Mar 20204:39 pmRNSPrice Monitoring Extension
17th Mar 202012:03 pmRNSPrice Monitoring Extension
27th Feb 202010:38 amRNSDirector/PDMR Shareholding
26th Feb 20207:00 amRNSPresentation Cowen Annual Health Care Conference
17th Feb 20207:00 amRNSTotal Voting Rights
14th Feb 20202:46 pmRNSHolding(s) in Company
4th Feb 20207:00 amRNSConfidential submission of Form F-1 to SEC
4th Feb 20207:00 amRNSTrading Update
27th Jan 20201:51 pmRNSBlock Listing Six Monthly Return
14th Jan 20207:00 amRNSUpdate on Base Editing Technology License
18th Dec 20197:00 amRNSPresentation at J.P. Morgan Healthcare Conference
16th Dec 201912:07 pmRNSSecond Price Monitoring Extn
16th Dec 201912:02 pmRNSPrice Monitoring Extension
13th Dec 20197:00 amRNSCollaboration with Mammoth Biosciences
4th Dec 201912:08 pmRNSSecond Price Monitoring Extn
4th Dec 201912:02 pmRNSPrice Monitoring Extension
4th Dec 20197:00 amRNSCompletion of Divestment of In Vivo Business Unit
8th Nov 20197:00 amRNSDivestment of In Vivo Business Unit
22nd Oct 20193:22 pmRNSAdditional Block Listing and Total Voting Rights
4th Oct 201912:07 pmRNSSecond Price Monitoring Extn
4th Oct 201912:02 pmRNSPrice Monitoring Extension
19th Sep 20193:30 pmRNSHolding(s) in Company
16th Sep 20197:00 amRNSHalf-year Report
12th Aug 201912:07 pmRNSSecond Price Monitoring Extn
12th Aug 201912:02 pmRNSPrice Monitoring Extension
26th Jul 20197:00 amRNSBlock Listing Six Monthly Return

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.